Janus Henderson Group PLC Legend Biotech Corp Transaction History
Janus Henderson Group PLC
- $178 Billion
- Q1 2024
A detailed history of Janus Henderson Group PLC transactions in Legend Biotech Corp stock. As of the latest transaction made, Janus Henderson Group PLC holds 2,014,012 shares of LEGN stock, worth $87.6 Million. This represents 0.06% of its overall portfolio holdings.
Number of Shares
2,014,012
Previous 1,865,157
7.98%
Holding current value
$87.6 Million
Previous $112 Million
0.66%
% of portfolio
0.06%
Previous 0.07%
Shares
8 transactions
Others Institutions Holding LEGN
# of Institutions
213Shares Held
63.6MCall Options Held
1.09MPut Options Held
525K-
Price T Rowe Associates Inc Baltimore, MD10.9MShares$477 Million0.08% of portfolio
-
Hhlr Advisors, Ltd. Grand Cayman, E95.98MShares$260 Million7.45% of portfolio
-
Black Rock Inc. New York, NY5.38MShares$234 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA2.61MShares$114 Million0.03% of portfolio
-
Capital World Investors Los Angeles, CA2.39MShares$104 Million0.02% of portfolio
About Legend Biotech Corp
- Ticker LEGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 167,403,008
- Market Cap $7.29B
- Description
- Legend Biotech Corporation, a clinical-stage biopharmaceutical company, through its subsidiaries, engages in the discovery and development of novel cell therapies for oncology and other indications in the United States, China, and internationally. Its lead product candidate, LCAR- B38M, is a chimeric antigen receptor for the treatment of multipl...